Ibrance
Product Images NDC 63539-187

This is a clinical trial data that compares the Progression-Free Survival Probability between palbociclib + fulvestrant and placebo + fulvestrant. The trial involves a total of 528 patients and the follow-up period lasted 22 months. Further information about the trial is not available.*

This is a study evaluating the overall survival probability of patients who received either palbociclib and fulvestrant or placebo and fulvestrant. The data shows the number of patients at each time point (in months) and the percentage of survival probability.*

This is a description of a company that is distributing a product through its subsidiary. The name of the company is Pfizer Labs, which is a division of Pfizer Inc in New York City, with the zip code of 10017.*

This is a description of a company which distributes products made by Pfizer Labs, a division of Pfizer Inc, based in New York City with zip code 10017.*

This is a prescription drug named "Ibrance (palbociclib) capsules" meant for Oncology Use only. The drug should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and can be kept between 15 to 30°C (59°F to 86°F) for a short time. It should be kept in a tightly sealed child-resistant container. The drug contains 125 mg of palbociclib per capsule. The prescribing information should be referred for dosage and usage details. This drug is distributed by U.S. Pharmaceuticals Piizer Inc, NY, NY 10017, and is made in Ireland. This is a professional sample and is not for sale. The expiry date is not available.*

This text is a set of instructions, warnings, and information about a medicine called Ibrance. It should be stored between 20°C and 25°C, with some temperature variations allowed, and dispensed in child-resistant containers. The dosage and usage information are not provided in the text but can be found in the accompanying prescribing information. Each capsule contains 100mg of Palbociclb, and it is distributed by USS Pharmaceuticals, belonging to Pfizer Inc. This is a professional sample and not for sale. The NDC of the product is 63539-188-11, and it includes 21 capsules. There is a lot and expiration date mentioned but not disclosed in this text.*

This is information about the prescription drug Ibrance (palbociclib) capsules. It should be stored between 20°C to 25°C (68°F to 77°F) but can tolerate excursions between 15°C and 30°C (59°F to 86°F). The capsules should be dispensed in child-resistant containers. Each capsule contains 75 mg of palbociclb. It is distributed by USS Pharmaceuticals, made in Ireland, and the package is a professional sample, not for sale. For dosage and usage instructions, refer to the accompanying prescribing information. The packaging contains 21 capsules, and it is only available for prescription. The label also includes the NDC 63539-187-11 and lot number PAA084872.*